Furthermore, tau haplotypes differed between PAOS-CBD and PAOS-PSP, suggesting that PAOS-PSP, in particular, may have a unique genetic risk profile, albeit with similar tau biochemistry. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.